Gm Advisory Group, Inc. Bausch Health Companies Inc. Transaction History

Gm Advisory Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$21.6 - $27.79 $173,880 - $223,709	-8,050 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $36,308 - $43,587	-1,450 Reduced 15.26%	8,050 $224,000
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $13,715 - $16,350	-500 Reduced 5.0%	9,500 $279,000
Q1 2021 May 13, 2021	SELL	$21.37 - $34.38 $42,740 - $68,760	-2,000 Reduced 16.67%	10,000 $317,000
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $306,200 - $422,400	-20,000 Reduced 62.5%	12,000 $249,000

Q3 2020 Nov 12, 2020	BUY	$14.88 - $20.13 $476,160 - $644,160	32,000 New	32,000 $497,000

281

278M

21.5M

21.8M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.57B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Gm Advisory Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Gm Advisory Group, Inc. with notifications on news.